These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24419900)

  • 1. Enhanced production of the nonribosomal peptide antibiotic valinomycin in Escherichia coli through small-scale high cell density fed-batch cultivation.
    Li J; Jaitzig J; Hillig F; Süssmuth R; Neubauer P
    Appl Microbiol Biotechnol; 2014 Jan; 98(2):591-601. PubMed ID: 24419900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scale-up bioprocess development for production of the antibiotic valinomycin in Escherichia coli based on consistent fed-batch cultivations.
    Li J; Jaitzig J; Lu P; Süssmuth RD; Neubauer P
    Microb Cell Fact; 2015 Jun; 14():83. PubMed ID: 26063334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstituted biosynthesis of the nonribosomal macrolactone antibiotic valinomycin in Escherichia coli.
    Jaitzig J; Li J; Süssmuth RD; Neubauer P
    ACS Synth Biol; 2014 Jul; 3(7):432-8. PubMed ID: 24350980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type II thioesterase improves heterologous biosynthesis of valinomycin in Escherichia coli.
    Li J; Jaitzig J; Theuer L; Legala OE; Süssmuth RD; Neubauer P
    J Biotechnol; 2015 Jan; 193():16-22. PubMed ID: 25449019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stapled NRPS enhances the production of valinomycin in Escherichia coli.
    Huang S; Ba F; Liu WQ; Li J
    Biotechnol Bioeng; 2023 Mar; 120(3):793-802. PubMed ID: 36510694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total in vitro biosynthesis of the nonribosomal macrolactone peptide valinomycin.
    Zhuang L; Huang S; Liu WQ; Karim AS; Jewett MC; Li J
    Metab Eng; 2020 Jul; 60():37-44. PubMed ID: 32224263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].
    Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the biosynthetic codes for the potent anti-SARS-CoV cyclodepsipeptide valinomycin in Streptomyces tsusimaensis ATCC 15141.
    Cheng YQ
    Chembiochem; 2006 Mar; 7(3):471-7. PubMed ID: 16511823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2].
    Shin CS; Hong MS; Bae CS; Lee J
    Biotechnol Prog; 1997; 13(3):249-57. PubMed ID: 9190075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escherichia coli as a cell factory for heterologous production of nonribosomal peptides and polyketides.
    Li J; Neubauer P
    N Biotechnol; 2014 Dec; 31(6):579-85. PubMed ID: 24704144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of recombinant bacteriocin divercin V41 by high cell density Escherichia coli batch and fed-batch cultures.
    Yildirim S; Konrad D; Calvez S; Drider D; Prévost H; Lacroix C
    Appl Microbiol Biotechnol; 2007 Dec; 77(3):525-31. PubMed ID: 17882416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total biosynthesis of antitumor nonribosomal peptides in Escherichia coli.
    Watanabe K; Hotta K; Praseuth AP; Koketsu K; Migita A; Boddy CN; Wang CC; Oguri H; Oikawa H
    Nat Chem Biol; 2006 Aug; 2(8):423-8. PubMed ID: 16799553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model based optimization of the fed-batch production of a highly active transglutaminase variant in Escherichia coli.
    Sommer C; Volk N; Pietzsch M
    Protein Expr Purif; 2011 May; 77(1):9-19. PubMed ID: 21168505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-limited high cell density cultivations from small to pilot plant scale using an enzyme-controlled glucose delivery system.
    Glazyrina J; Krause M; Junne S; Glauche F; Storm D; Neubauer P
    N Biotechnol; 2012 Jan; 29(2):235-42. PubMed ID: 22100433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode.
    Borja GM; Meza Mora E; Barrón B; Gosset G; Ramírez OT; Lara AR
    Microb Cell Fact; 2012 Sep; 11():132. PubMed ID: 22992433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design and metabolic analysis of Escherichia coli for effective production of L-tryptophan at high concentration.
    Chen L; Zeng AP
    Appl Microbiol Biotechnol; 2017 Jan; 101(2):559-568. PubMed ID: 27599980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of engineered Escherichia coli AF1000 and BL21 strains for (R)-3-hydroxybutyrate production in fed-batch cultivation.
    Perez-Zabaleta M; Guevara-Martínez M; Gustavsson M; Quillaguamán J; Larsson G; van Maris AJA
    Appl Microbiol Biotechnol; 2019 Jul; 103(14):5627-5639. PubMed ID: 31104101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo biosynthesis of complex natural product sakuranetin using modular co-culture engineering.
    Wang X; Li Z; Policarpio L; Koffas MAG; Zhang H
    Appl Microbiol Biotechnol; 2020 Jun; 104(11):4849-4861. PubMed ID: 32285175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitreoscilla hemoglobin expression in engineered Escherichia coli: improved performance in high cell-density batch cultivations.
    Pablos TE; Mora EM; Le Borgne S; Ramírez OT; Gosset G; Lara AR
    Biotechnol J; 2011 Aug; 6(8):993-1002. PubMed ID: 21744499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Engineered Synthetic Pathway for Discovering Nonnatural Nonribosomal Peptides in
    Cleto S; Lu TK
    mBio; 2017 Oct; 8(5):. PubMed ID: 29018120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.